Kiss Products expands line with new handle-less hair dryer
NEW YORK — Nail care company Kiss Products has expanded its portfolio to include an array of beauty products, including the new Red by Kiss Handle-Less 1875W hair dryer.
Launched in May with a suggested retail price of $29.99, the new hair dryer is optimized for pik hair straightening and drying for African-American users. It is also designed to deliver more comfortable hair styling with a round or paddle brush for general users.
Additional features include ceramic tourmaline technology, three heat and two air speed settings, a bonus concentrator and two piks.
Wegmans awards $4.9 million in college tuition assistance to employees
ROCHESTER, N.Y. — Wegmans Food Markets on Tuesday announced that the Wegmans Employee Scholarship Program will award college tuition assistance to 1,766 new recipients for the upcoming academic year. Wegmans expects to pay out more than $4.9 million in tuition assistance to both new and returning scholarship recipients during the 2014/2015 school year.
Since the program began in 1984, more than 30,000 Wegmans employees have been awarded scholarships totaling $95 million. The first class of Wegmans scholarship recipients in the 1984/1985 academic year included 241 employees with scholarships totaling $280,000.
“My grandfather established this long-standing tradition with the aim of helping young people succeed,” stated Wegmans president Colleen Wegman. “The program has grown considerably, and we’re proud to continue helping our people reach their academic and career goals.”
Sanofi proposes to switch Cialis OTC
PARIS — Sanofi and Eli Lilly and Co. on Wednesday announced an agreement to pursue regulatory approval of nonprescription Cialis (tadalafil). Cialis is currently available by prescription only worldwide for the treatment of men with erectile dysfunction.
"This agreement provides us with an opportunity to work with Lilly, a leader in men’s health, to transform how this important medicine is offered to millions of men throughout the world," stated Vincent Warnery, SVP global consumer healthcare division, Sanofi. "The opportunity to forge an industry-leading partnership that adds to Sanofi Consumer Healthcare’s leading portfolio and successful track record of over-the-counter switches reinforces consumer health care as a major growth platform for Sanofi."
"Millions of men worldwide trust Cialis to treat ED. We are pleased to work with Sanofi to pursue a path that could allow more men who suffer from ED to obtain convenient access to a safe and reliable product without a prescription," added David Ricks, SVP Lilly, and president Lilly Bio-Medicines. "Switching a medicine to over-the-counter is a highly regulated process that is data-driven and scientifically rigorous. Together with Sanofi, we look forward to working closely with regulatory authorities to define the proper actions and necessary precautions to help patients use over-the-counter Cialis appropriately."
Under the terms of the agreement, Sanofi acquires the exclusive rights to apply for approval of Cialis OTC in the United States, Europe, Canada and Australia. Sanofi also holds exclusive rights to market Cialis OTC following Sanofi’s receipt of all necessary regulatory approvals. If approved, Sanofi anticipates providing Cialis OTC after expiration of certain patents.
Terms of the licensing agreement were not disclosed.
Cialis was first approved by the European Medicines Agency in 2002, then by the U.S. Food and Drug Administration in 2003, for the treatment of erectile dysfunction. Ultimately, Cialis has received approval in more than 120 countries for indications that vary by country. Cialis reached $2.2 billion in worldwide sales in 2013 and has recorded total global sales of more than $14 billion since launch.
To date, more than 45 million men worldwide have been treated with Cialis, the companies stated.